NASDAQ:HLVX

HilleVax (HLVX) Stock Forecast, Price & News

$13.45

-0.03 (-0.22%)

(As of 09/29/2023 ET)

Compare

Today's Range: $13.20
▼
$13.58
50-Day Range: $11.59
▼
$15.58
52-Week Range: $11.35
▼
$23.10

Volume: 46,199 shs
Average Volume: 88,393 shs
Market Capitalization: $651.21 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

HilleVax MarketRank™ Forecast

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: Bearish
6.71% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.74
Based on 5 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Decreasing
From ($3.30) to ($3.51) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

0.90 out of 5 stars

Medical Sector

960th out of 972 stocks

Biological Products, Except Diagnostic Industry

154th out of 156 stocks

N/A

Analyst's Opinion

Consensus Rating
There is not enough analysis data for HilleVax.

0.0

Short Interest

Percentage of Shares Shorted
6.71% of the float of HilleVax has been sold short.
Short Interest Ratio / Days to Cover
HilleVax has a short interest ratio ("days to cover") of 11.6, which indicates bearish sentiment.
Change versus previous month
Short interest in HilleVax has recently increased by 5.81%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
HilleVax does not currently pay a dividend.
Dividend Growth
HilleVax does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for HLVX.

2.1

News and Social Media Coverage

News Sentiment
HilleVax has a news sentiment score of 0.74. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 5 news articles for HilleVax this week, compared to 1 article on an average week.
Search Interest
Only 1 people have searched for HLVX on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

3.3

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, HilleVax insiders have not sold or bought any company stock.
Percentage Held by Insiders
29.30% of the stock of HilleVax is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
89.77% of the stock of HilleVax is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.0

Earnings and Valuation

Earnings Growth
Earnings for HilleVax are expected to decrease in the coming year, from ($3.30) to ($3.51) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of HilleVax is -5.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of HilleVax is -5.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
HilleVax has a P/B Ratio of 1.68. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About HilleVax (NASDAQ:HLVX) Stock

HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. The company develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus and related illness. The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in February 2021. HilleVax, Inc. was founded in 2019 and is headquartered in Boston, Massachusetts.

HLVX Price History

30 days | 90 days | 365 days | Advanced Chart

HLVX Stock News Headlines

September 26, 2023 | finance.yahoo.com

HilleVax to Participate in Fireside Chat at the 2023 Cantor Global Healthcare Conference

September 25, 2023 | benzinga.com

HilleVax Announces Closing of Public Offering of Common Stock and Full Exercise of the Underwriters' Option to Purchase Additional Shares

October 1, 2023 | Legacy Research (Ad)

Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video)

“Hi, I’m Teeka Tiwari...I’m about to get in this Tesla and drive up to a facility just a few miles from here to show you what could be the secret behind Elon Musk’s new AI project… What happens next will shock you…”

September 25, 2023 | finance.yahoo.com

HilleVax Announces Closing of Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

September 24, 2023 | americanbankingnews.com

HilleVax (NASDAQ:HLVX) Shares Down 2.9%

September 23, 2023 | finance.yahoo.com

Owning 32% shares,institutional owners seem interested in HilleVax, Inc. (NASDAQ:HLVX),

September 20, 2023 | benzinga.com

Why HilleVax Shares Are Trading Lower

September 20, 2023 | markets.businessinsider.com

Pre-market Movers: SPRY, SNTG, PODC, EXAI, BJDX…

October 1, 2023 | Legacy Research (Ad)

Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video)

September 19, 2023 | finance.yahoo.com

HilleVax Announces Pricing of Public Offering of Common Stock

September 19, 2023 | finance.yahoo.com

HilleVax Announces Proposed Public Offering of Common Stock

August 30, 2023 | msn.com

HilleVax: Takeda's Norovirus Vaccine Spinout

August 14, 2023 | bizjournals.com

Biotech behind 2022's largest local IPO delays norovirus vaccine

August 14, 2023 | msn.com

HilleVax GAAP EPS of -$0.74

August 14, 2023 | finanznachrichten.de

HilleVax, Inc.: HilleVax Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress

August 14, 2023 | finance.yahoo.com

HilleVax Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress

June 7, 2023 | finance.yahoo.com

Wall Street Analysts Predict a 56.76% Upside in HilleVax, Inc. (HLVX): Here's What You Should Know

June 7, 2023 | finance.yahoo.com

Wall Street Analysts Predict a 56.76% Upside in HilleVax, Inc. (HLVX): Here's What You Should Know

May 30, 2023 | markets.businessinsider.com

Stifel Nicolaus Sticks to Its Buy Rating for HilleVax, Inc (HLVX)

May 25, 2023 | markets.businessinsider.com

Stifel Nicolaus Reaffirms Their Buy Rating on HilleVax, Inc (HLVX)

May 22, 2023 | finance.yahoo.com

How Much Upside is Left in HilleVax, Inc. (HLVX)? Wall Street Analysts Think 87.76%

May 16, 2023 | msn.com

JP Morgan Maintains HilleVax (HLVX) Overweight Recommendation

May 16, 2023 | markets.businessinsider.com

J.P. Morgan Keeps Their Buy Rating on HilleVax, Inc (HLVX)

May 13, 2023 | finanznachrichten.de

HilleVax, Inc.: HilleVax Reports First Quarter 2023 Financial Results and Highlights Recent Company Progress

May 12, 2023 | msn.com

HilleVax: Q1 Earnings Insights

May 12, 2023 | finance.yahoo.com

HilleVax Reports First Quarter 2023 Financial Results and Highlights Recent Company Progress

May 9, 2023 | finance.yahoo.com

HilleVax Announces Appointment of Nanette Cocero Ph.D., MBA, to its Board of Directors

See More Headlines

Receive HLVX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HilleVax and its competitors with MarketBeat's FREE daily newsletter.

HLVX Company Calendar

Last Earnings: 8/14/2023
Today: 10/01/2023
Next Earnings (Estimated): 11/09/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biological products, except diagnostic
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:HLVX
CUSIP: N/A
CIK: 1888012
Web: www.hillevax.com
Phone: 617-213-5054
Fax: N/A
Employees: 62
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($2.46)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-159,810,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -36.52%
Return on Assets: -30.25%

Debt

Debt-to-Equity Ratio: 0.11
Current Ratio: 13.80
Quick Ratio: 13.80

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $8.01 per share
Price / Book: 1.68

Miscellaneous

Outstanding Shares: 48,420,000
Free Float: 34,231,000
Market Cap: $651.25 million
Optionable: Not Optionable
Beta: 0.03

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

Dr. Robert M. Hershberg M.D. (Age 61)
Ph.D., Pres, CEO & Chairman
Comp: $1.02M

Mr. Aditya Kohli Ph.D. (Age 35)
COO & Director
Comp: $782.44k

Mr. David A. Socks (Age 48)
Chief Bus. Officer
Comp: $709.59k

Mr. Shane A. Maltbie (Age 41)
CFO & Treasurer

Dr. Anju Chatterji Ph.D.
Chief Technology Officer

Mr. Paul S. Bavier J.D. (Age 51)
Gen. Counsel, Sec. & Chief Admin. Officer

Ms. Astrid Borkowski M.D. (Age 53)
Ph.D., Chief Medical Officer

Mr. Ozzie Berger
Sr. VP of Regulatory Affairs

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

HLVX Stock - Frequently Asked Questions

How have HLVX shares performed in 2023?: HilleVax's stock was trading at $16.73 at the beginning of 2023. Since then, HLVX stock has decreased by 19.6% and is now trading at $13.45.
View the best growth stocks for 2023 here.
Are investors shorting HilleVax?: HilleVax saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 672,000 shares, an increase of 5.8% from the August 31st total of 635,100 shares. Based on an average daily trading volume, of 58,000 shares, the days-to-cover ratio is presently 11.6 days. Currently, 6.7% of the shares of the company are sold short.
View HilleVax's Short Interest.
When is HilleVax's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, November 9th 2023.
View our HLVX earnings forecast.
How were HilleVax's earnings last quarter?: HilleVax, Inc. (NASDAQ:HLVX) announced its quarterly earnings data on Monday, August, 14th. The company reported ($0.74) earnings per share for the quarter, topping analysts' consensus estimates of ($0.85) by $0.11.
What ETFs hold HilleVax's stock?: ETFs with the largest weight of HilleVax (NASDAQ:HLVX) stock in their portfolio include Morningstar US Small Growth (MSGR).ETFMG Treatments Testing and Advancements ETF (GERM).

When did HilleVax IPO?: (HLVX) raised $200 million in an initial public offering (IPO) on Friday, April 29th 2022. The company issued 11,765,000 shares at a price of $16.00-$18.00 per share.
What is HilleVax's stock symbol?: HilleVax trades on the NASDAQ under the ticker symbol "HLVX."
How do I buy shares of HilleVax?: Shares of HLVX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is HilleVax's stock price today?: One share of HLVX stock can currently be purchased for approximately $13.45.
How much money does HilleVax make?: HilleVax (NASDAQ:HLVX) has a market capitalization of $651.25 million. The company earns $-159,810,000.00 in net income (profit) each year or ($2.46) on an earnings per share basis.
How can I contact HilleVax?: The official website for the company is www.hillevax.com. The company can be reached via phone at 617-213-5054 or via email at ir@hillevax.com.

This page (NASDAQ:HLVX) was last updated on 10/1/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial